NASDAQ:MDCO

The Medicines Stock Forecast, Price & News

Notice: This company has been marked as potentially delisted and may not be actively trading.
$84.90
0.00 (0.00 %)
(As of 01/6/2020)
Add
Compare
Today's Range
$84.90
$84.90
50-Day Range
$84.90
$84.90
52-Week Range
$17.81
$84.98
VolumeN/A
Average Volume9.55 million shs
Market Capitalization$6.77 billion
P/E RatioN/A
Dividend YieldN/A
Beta1.1

Receive MDCO News and Ratings via Email

Sign-up to receive the latest news and ratings for The Medicines and its competitors with MarketBeat's FREE daily newsletter.


The Medicines logo

About The Medicines

The Medicines Company, a biopharmaceutical company, focuses on developing therapeutics for the treatment of therosclerotic cardiovascular disease. The company is developing Inclisiran, an investigational RNA interference therapeutic that inhibits production of proprotein convertase subtilisin/kexin type 9, which controls LDL-cholesterol levels. It has collaboration agreement with Alnylam Pharmaceuticals, Inc. The Medicines Company was founded in 1996 and is headquartered in Parsippany, New Jersey.

Headlines

See More Headlines

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous


MarketRank

Overall MarketRank

0.96 out of 5 stars

Medical Sector

1239th out of 1,352 stocks

Pharmaceutical Preparations Industry

608th out of 665 stocks

Analyst Opinion: 0.0Community Rank: 4.8Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles











The Medicines (NASDAQ:MDCO) Frequently Asked Questions

What stocks does MarketBeat like better than The Medicines?

Wall Street analysts have given The Medicines a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but The Medicines wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

How were The Medicines' earnings last quarter?

The Medicines Company (NASDAQ:MDCO) posted its quarterly earnings results on Wednesday, October, 30th. The company reported ($0.92) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.80) by $0.12. During the same period in the previous year, the company posted ($0.70) earnings per share.
View The Medicines' earnings history
.

Who are The Medicines' key executives?

The Medicines' management team includes the following people:
  • Mr. Mark Timney, CEO & Director (Age 54)
  • Mr. Christopher J. Visioli, CFO & Treasurer (Age 43)
  • Mr. Stephen M. Rodin J.D., Exec. VP, Gen. Counsel & Sec. (Age 43)
  • Dr. Clive A. Meanwell, Chief Innovation Officer & Director (Age 61)
  • Dr. Goutham Krishna Gorti, VP & Head of Investor Relations

Who are some of The Medicines' key competitors?

What other stocks do shareholders of The Medicines own?

Based on aggregate information from My MarketBeat watchlists, some companies that other The Medicines investors own include Micron Technology (MU), NVIDIA (NVDA), AbbVie (ABBV), Gilead Sciences (GILD), Alibaba Group (BABA), salesforce.com (CRM), Bank of America (BAC), Ionis Pharmaceuticals (IONS), AT&T (T) and Alnylam Pharmaceuticals (ALNY).

What is The Medicines' stock symbol?

The Medicines trades on the NASDAQ under the ticker symbol "MDCO."

What is The Medicines' stock price today?

One share of MDCO stock can currently be purchased for approximately $84.90.

How much money does The Medicines make?

The Medicines has a market capitalization of $6.77 billion and generates $6.14 million in revenue each year. The company earns $-123,160,000.00 in net income (profit) each year or ($2.91) on an earnings per share basis.

How many employees does The Medicines have?

The Medicines employs 62 workers across the globe.

What is The Medicines' official website?

The official website for The Medicines is www.themedicinescompany.com.

Where are The Medicines' headquarters?

The Medicines is headquartered at 8 SYLVAN WAY, PARSIPPANY NJ, 07054.

How can I contact The Medicines?

The Medicines' mailing address is 8 SYLVAN WAY, PARSIPPANY NJ, 07054. The company can be reached via phone at 973-290-6000 or via email at [email protected].


This page was last updated on 9/21/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.